The AGRANA Research & Innovation Center (ARIC) is the AGRANA Group’s central research and development company. The aim of ARIC is to tap new fields of application for innovative products made from the raw materials potatoes, maize, waxy maize, wheat and sugar beet. ARIC is a national and international provider of research & development and other related services in the areas of sugar technology, food technology, starch technology, microbiology, biotechnology and fruit.
Pfizer Manufacturing Austria is Pfizer’s production site at Orth an der Donau. The plant meets global demand for vaccines to protect against tickborne encephalitis and meningitis caused by serogroup C meningococci.
The Novartis production plant located in Unterach am Attersee in Upper Austria develops and manufactures injectable drug specialties. The site is the Novartis Center of Competence for oncology injectables. The production site in Unterach belongs to the technology platform Aseptics in the Novartis Technical Operations Organization.
Sandoz’ mission is to discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high quality medicine. Sandoz GmbH, based in Kundl / Tyrol, is part of the Novartis Austria Group and is the largest domestic pharmaceutical manufacturer and exporter. In addition to antibiotics, Novartis biologics and Sandoz biosimilars are being created in Tyrol through specialization in biotechnological active ingredients and pharmaceutical products.
Founded in 1980, Amgen has grown to be one of the world's leading independent biotechnology companies. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses.
Novartis Pharma GmbH, based in Vienna, is one of the leading pharmaceutical companies in Austria. With its patented, prescription medicines for the treatment of a wide variety of diseases, the company meets important medical needs. Currently, Novartis Pharma GmbH conducts approximately 100 clinical trials in Austria, including a total of around 3000 patients.